Concepedia

Nicholas Otte

NO

Statistics

Publications

9

Citations

2.1K

H-Index

9

Active since

2012

Affiliations

The University of Sydney(Current)

Centenary Institute

Royal Prince Alfred Hospital

Prostate Cancer Foundation of Australia

University of California, Los Angeles

Nicholas Otte is an author at The University of Sydney specializing in oncology, molecular oncology, and medicine.

Publications per year

2012–2018

9

Publications

9

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Amaya Virós, Carla Milagre et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

Medicine, Dermatology, Oncology +13

Targeting <scp>ASCT2</scp>‐mediated glutamine uptake blocks prostate cancer growth and tumour development

Qian Wang, Rae‐Anne Hardie, Andrew J. Hoy et al. · The Journal of Pathology · 2015 · 330 citations · Full text

Life Sciences, Biochemistry, Oncology +17

BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy

Richard C. Koya, Stephen Mok, Nicholas Otte et al. · Cancer Research · 2012 · 233 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting glutamine transport to suppress melanoma cell growth

Qian Wang, Kimberley A. Beaumont, Nicholas Otte et al. · International Journal of Cancer · 2014 · 218 citations · Full text

Medicine, Cancer Biology, Oncology +17

ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma

Amy D. Marshall, Michelle van Geldermalsen, Nicholas Otte et al. · Oncogenesis · 2017 · 80 citations · Full text

Medicine, Molecular Biology, Oncology +10

1–5 of 9